Market Share Recovery
Challenge: Flagship product losing 15% market share to new generic competitors.
Strategy: Shifted focus from pricing to superior clinical efficacy. Organized 10 highly targeted KOL roundtables.
Result: Recovered 20% share within 6 months, establishing product as premium standard of care.
New Product Launch
Challenge: Launching a novel anti-diabetic in a highly saturated territory.
Strategy: Aggressive pre-launch scientific teaser campaigns and day-1 pharmacy stocking.
Result: Reached 100% of target prescribers in week one; achieved highest regional launch sales.
KOL Advocacy Building
Challenge: Top regional cardiologist was prescribing a competitor's brand exclusively.
Strategy: Shared continuous, peer-reviewed international clinical trial data over 3 months.
Result: Converted the KOL, leading to a cascading effect among junior doctors in the hospital.
Pharmacy Network Expansion
Challenge: Prescription bounce rates were high due to poor chemist availability.
Strategy: Mapped 50 key hospital-attached pharmacies and ensured automated stock replenishment.
Result: Reduced prescription bounce from 18% to 2%, directly boosting primary sales.
